Embryonic retina cAMP signaling

Embryonic retina cAMP signaling refers to the intracellular signaling cascade mediated by cyclic adenosine monophosphate (cAMP) during the development of the vertebrate retina. This pathway is not a single molecular entity but a complex network involving adenylate cyclases (ACs), phosphodiesterases (PDEs), and downstream effectors like Protein Kinase A (PKA) and Epac (Exchange Protein Directly Activated by cAMP). It plays a pivotal role in retinal ganglion cell (RGC) axon guidance, where the concentration of cAMP determines the growth cone's sensitivity and directional response to extracellular guidance cues such as Netrin-1 and Ephrins (Nicol et al., 2007, PubMed: 17622577). Furthermore, cAMP signaling is essential for the generation and modulation of spontaneous retinal waves, which are rhythmic bursts of action potentials that guide the activity-dependent refinement of visual maps in the brain (Stellwagen et al., 1999, PubMed: 10460254). Dysregulation of this pathway is implicated in neurodevelopmental visual disorders and optic nerve hypoplasia. While the pathway itself is a process, its individual components are targeted by various pharmacological agents, such as Forskolin and PDE inhibitors, to study neuronal regeneration and plasticity (Dyer et al., 2003, PubMed: 12657668).

Other names

cAMP signaling in retinal developmentRetinal cAMP-dependent pathwayCyclic adenosine monophosphate signaling in embryonic retina

The pathway is modulated by drugs that either increase cAMP production via adenylate cyclase activation or decrease cAMP degradation via phosphodiesterase inhibition, thereby altering the activity of PKA and Epac to influence neuronal growth and connectivity.